Voices from the Doximity Network
Shiv Kumar Goel, MD
Mar 2, 2026
Madhu Pamganamamula, MD
Feb 23, 2026 Link to Rethinking Obesity Care in the Era of Incretin Mimetics
Aditya Jain
Jan 12, 2026 Link to Health is Our Greatest Asset … So Why Doesn’t Insurance Treat it as Such?
Joseph Philip Zucchi, PA
Sep 18, 2025 Link to Obesity Meds Advance, Insurance Retreats: A Costly Step Back for Health
Ashley Evette Ingram-T'Siobbel, DNP
Jul 21, 2025 Link to Colonoscopy Prep and GLP-1 Agonists: Rethinking the Timeline for Safe Screening
Jacob Murphy, MD
Jun 2, 2025 Link to GLP-1s: Hims, Hers, Whose?
Christopher McGowan, MD
Mar 24, 2025 Link to I No Longer Think GLP-1s Are the Answer
Abraham Kim
Mar 10, 2025 Link to How Clinicians Approach GLP-1s for Weight Loss Management
Lisa Belisle, MD
Sep 23, 2024 Link to There Is No Magic Solution to Weight Loss: How to Help Patients in the Age of GLP-1s
Sep 3, 2024 Link to The Expanding Universe of GLP-1 Medications: A Revolution Beyond Diabetes and Weight Loss
Shubham Agarwal, MD
Jul 1, 2024 Link to Future of Diabetes Management: Interconnected Chronic Disease Care at ADA 2024
Sara Jane Cromer, MD
Jul 1, 2024 Link to Prioritization of GLP1-RA and Dual Agonists in an Era of Shortages
Amber Healy, DO
Jul 1, 2024 Link to Facts, Fiction, and Myths Around GLP-1s Discussed at the ADA Scientific Sessions
Byron J Hoogwerf, MD
Jul 1, 2024 Link to GLP-1 RAs: Beyond Glycemic Control to Cardiovascular, Renal, and Liver Benefits
Nuzhat (Kisat) Chalisa, MD, FACE, DABOM
Jul 1, 2024 Link to GLP-1 in the Spotlight: Key Takeaways from the 2024 ADA Conference
Apr 8, 2024 Link to The Dangers of Compounded Obesity Medications
Ryan Richman, MD
Nov 27, 2023 Link to How GLP-1s are Like Antibiotics
Payal Kohli, MD, FACC
Nov 6, 2023 Link to My Approach to GLP-1s: Great Power, Great Responsibility